Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Heart and vascular responses across the lifespan in Ts65Dn mice, a model of Down syndrome
Data Coordinating Center for Artificial Pancreas Studies
Gene regulation involved in plasticity of olfactory system
SBE: Option: Small: Safety for the Ages: Generational Differences in Motivations to Use Security Protections in an Online Banking Context
Stable Isotope Probing to Assess Bioremediation of LUST Contaminants: Addressing Existing MTBE/BTEX and Probable Future Ethanol/BTEX Contamination
Recently added grants:
Correction of endocrine disruptor-induced transgenerational epimutations by CRISPR-dCas9
Gap Junctional Patterning in the Arrhythmic Heart
Role of RhoA in the Molecular Pathogenesis of Heart Disease.
Axes of Oncometabolism in the Heart
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07160-32-0-1
Application #
7575499
Study Section
Project Start
2000-08-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Clinical Trials and Surveys Corporation
$1,684,146
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial - Mcc
Thompson, Bruce W. /
$250,000
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant